Straight talk: Adult and embryonic stem cells and the future of research

July 13, 2003

At an American Association for Cancer Research forum designed to provide straight talk on what's known -- and what isn't known -- about the primitive precursor cells that act as a reservoir of new cells in the body, Johns Hopkins' Curt Civin, M.D., will lead a discussion about stem cell research and policy and their relation to cancer research. The forum is scheduled for July 13 at the Washington, D.C., meeting.

While stem cells found in the blood and bone marrow, so-called hematopoietic stem cells, have been studied for 20 years, more primitive stem cells obtained from embryos have revolutionized stem cell research, says Civin, professor of oncology at the Johns Hopkins Kimmel Cancer Center.

Previewing the discussion, Civin says that "until 1998, 'stem cells' were hematopoietic stem cells; no other kind was known in people. Now, the potential of stem cells from embryos to shed light on basic biology, human development and genetic diseases, and to someday offer ways to treat incurable and fatal diseases has made us re-examine what we think we know about stem cells from the blood and other tissues."

Blood-forming stem cells and other more specialized stem cells from specific tissues or organs are known as "adult" stem cells even if found in newborns or children. Darwin Prockop, from the Gene Therapy Center at Tulane University Medical Center, will recap advances with adult stem cells, which seem to be capable of becoming more cell types than once thought. Irving Weissman, from Stanford University, will discuss the current status of embryonic stem cell research and where it is heading.

"Right now, scientists are just learning about the biology of human embryonic stem cells and how to grow them reliably -- things we've known about hematopoietic stem cells for 20 years or longer," says Civin. "But embryonic stem cells are ahead of adult stem cells in making a wide variety of different cell types on demand."

People's opinions differ widely on whether using leftover in vitro fertilization embryos to gather embryonic stem cells is acceptable, particularly on whether obtaining the stem cells is destroying a "life." Cells from newborns or more grown-up humans don't pose the same dilemma, prompting a repeated question, says Civin.

"People always ask if the new finding -- whatever it is -- means that scientific and medical goals could be accomplished by researching only 'adult' stem cells to avoid the ethical debate," he says. "The bottom line is that we don't know enough to answer that question, and we won't for some time."

One hurdle to understanding the differences between embryonic and adult stem cells is political indecisiveness, says Civin, who will open the AACR session by describing a current effort in the Maryland legislature. A proposed bill would try to make Maryland an attractive place for research using human embryonic stem cells, in part by setting up framework for research on somatic cell nuclear transfer techniques with human cells, widely known as therapeutic cloning.

Among other things, proponents say developing the technique -- far from a "gimmee" -- could help unravel the processes that lead directly to many genetic diseases, including cancers. By creating a line of embryonic stem cells from a person with such a condition, scientists could study how that genetic change affects cells in early development -- currently impossible to examine -- and farther along the path from embryonic cell to a particular type of cell (mammary cell, prostate cell, ovary cell, etc.).

"How does the genetic change affect the signals that tell cells to divide or stop dividing, or what type of cell to become? In cancer, a disease of abnormal cell growth, that's an extremely important question, and it's hard to think of a more direct way to investigate it," says Civin.

Criticizing policies that would limit study to only stem cells from "adult" tissue, or from embryonic tissue, Civin says the key to making progress scientifically, which eventually improves medicine, is to approach a question from a number of angles. Limiting the approaches slows discovery and prevents validation of results, he says.

"What if 20 years ago the government had decided that computed tomography should be set aside and work should only continue on magnetic resonance imaging, say, because it doesn't involve radioactivity?" asks Civin. "At the time, no one knew if one would turn out to be better, and as fate would have it, each has its niche, even today."

Similarly, he says, pursuing research with both embryonic stem cells and adult stem cells is the most reasonable way to learn what scientists and doctors don't know about stem cells.

"Stem cells from all sources have potential to reveal answers to biology's great mysteries and someday to impact medicine," he says, "and the constant cry to try to use stem cells from only one source is counter to how science is done best."
-end-
Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at http://www.eurekalert.org and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://www.hopkinsmedicine.org

Johns Hopkins Medicine

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.